PRESS RELEASE published on 02/21/2023 at 14:30, 2 years ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 2 years 1 month ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 2 years 1 month ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 2 years 1 month ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 2 years 1 month ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 2 years 1 month ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 2 years 1 month ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Published on 03/18/2025 at 11:00, 30 minutes ago Fineqia AG Partners with ETPLink to Drive Primary Market Efficiency
Published on 03/18/2025 at 02:00, 9 hours 30 minutes ago Gold Mountain Reports its Interim Q4 2025 Financial and Operating Results
Published on 03/18/2025 at 01:00, 10 hours 30 minutes ago Gold Mountain Announces Change in Financial Year-End
Published on 03/17/2025 at 23:15, 12 hours 15 minutes ago Presentation to Swiss Mining Institute Conference
Published on 03/18/2025 at 11:00, 30 minutes ago DATAGROUP publishes guidance for fiscal year 2024/2025
Published on 03/18/2025 at 11:00, 30 minutes ago Academic study shows significant cost differences in crypto trading
Published on 03/18/2025 at 10:43, 47 minutes ago Sitka Gold: First drill hole 2025 shows 130 instances of visible gold
Published on 03/18/2025 at 10:00, 1 hour 30 minutes ago Innomotics chosen as nominated partner for the new AirTrain at Newark International Airport
Published on 03/18/2025 at 09:59, 1 hour 30 minutes ago First regulated financial market infrastructure for trading and settlement of digital assets in Switzerland
Published on 03/18/2025 at 08:30, 3 hours ago Cie du Bois Sauvage: Buy back of own shares – week from 10/03/2025 to 14/03/2025
Published on 03/18/2025 at 07:01, 4 hours 29 minutes ago bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
Published on 03/18/2025 at 07:00, 4 hours 30 minutes ago Peugeot Invest successfully sold half of its stake in SPIE
Published on 03/17/2025 at 19:15, 16 hours 15 minutes ago OLIVIER MILLET, MEMBER OF THE EXECUTIVE BOARD, STEPS DOWN AS PART OF A SUCCESSFUL MANAGEMENT TRANSITION
